Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Evaluation of HEMOBLAST™ Bellows Performance and Safety in Laparoscopic Abdominal, Gynecological and Urological Surgery

NCT03873181 is registered in ClinicalTrials.gov with Biom'Up France SAS as lead sponsor.

NCT NCT03873181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Evaluation of HEMOBLAST™ Bellows Performance and Safety in Laparoscopic Abdominal, Gynecological and Urological Surgery
Lead sponsor
Biom'Up France SAS
Phase
Observational
Overall status
Completed
Start date
May 16, 2019
Completion date
August 26, 2020
Enrollment
102 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis